Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa
March 27, 2024 08:00 ET
|
Vector Pharma FZCO; Oncopeptides AB
Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa
Vector Pharma FZCO Announce Exclusive Distribution Agreement with Ascendis Pharma A/S for Skytrofa (lonapegsomatropin) and Yorvipath (palopegteriparatide) in Gulf Cooperation Council Countries
January 08, 2024 08:20 ET
|
Vector Pharma FZCO
Vector Pharma FZCO Announce Exclusive Distribution Agreement with Ascendis Pharma A/S
Vector Pharma FZCO signs Exclusive License and Distribution Rights to IXEMPRA in the Middle East
December 22, 2021 08:00 ET
|
Vector Pharma FZCO
DUBAI, United Arab Emirates, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Vector Pharma FZCO announced today the signing of an exclusive distribution agreement with R-PHARM US of Princeton, NJ . Under the...